We are live on ! Find out more
Squarepoint

Squarepoint Portfolio holdings

AUM $85.1B
1-Year Est. Return 20.93%
This Fund
S&P 500
This Quarter Est. Return
-0.06%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$60.5B
AUM Growth
+$2.39B
Cap. Flow
+$1.77B
Cap. Flow %
2.93%
Top 10 Hldgs %
17.56%
Holding
4,827
New
882
Increased
1,455
Reduced
1,567
Closed
849

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$210M
2
UNH icon
UnitedHealth
UNH
+$158M
3
NFLX icon
Netflix
NFLX
+$140M
4
DG icon
Dollar General
DG
+$135M
5
MU icon
Micron Technology
MU
+$124M

Sector Composition

Rank Sector Weight
1 Technology 9.07%
2 Consumer Discretionary 6.01%
3 Healthcare 4.63%
4 Industrials 4.29%
5 Financials 4.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DC icon
3801
Dakota Gold
DC
$623M
$96.5K ﹤0.01%
+37,860
New +$101K
LNZA icon
3802
LanzaTech
LNZA
$61.3M
$96.2K ﹤0.01%
520
+53
+11% +$13.5K
APLT
3803
DELISTED
Applied Therapeutics
APLT
$95.6K ﹤0.01%
20,478
-173,280
-89% -$820K
SCYX icon
3804
SCYNEXIS
SCYX
$37M
$95.6K ﹤0.01%
5,975
-12,710
-68% -$196K
JBIO
3805
Jade Biosciences
JBIO
$1.22B
$94.8K ﹤0.01%
+1,631
New +$1.08M
CTOS icon
3806
Custom Truck One Source
CTOS
$2.47B
$94.3K ﹤0.01%
+21,685
New +$106K
HFFG icon
3807
HF Foods Group
HFFG
$82.9M
$93.5K ﹤0.01%
31,177
-14,251
-31% -$45.3K
LL
3808
DELISTED
LL Flooring Holdings, Inc.
LL
$92.8K ﹤0.01%
64,860
+22,080
+52% +$35.4K
IDN icon
3809
Intellicheck
IDN
$73.5M
$91.3K ﹤0.01%
26,682
-9,321
-26% -$30.4K
SRTS icon
3810
Sensus Healthcare
SRTS
$49.9M
$90.7K ﹤0.01%
17,020
+4,273
+34% +$19.6K
SGHT icon
3811
Sight Sciences
SGHT
$267M
$87.8K ﹤0.01%
13,159
-41,809
-76% -$247K
NG icon
3812
NovaGold Resources
NG
$2.6B
$86.9K ﹤0.01%
25,109
+6,080
+32% +$20.2K
AQST icon
3813
Aquestive Therapeutics
AQST
$462M
$86.8K ﹤0.01%
33,401
-5,845
-15% -$19.5K
SGHC icon
3814
SGHC Ltd
SGHC
$7.3B
$86.6K ﹤0.01%
26,826
-13,094
-33% -$44.2K
ZJYL icon
3815
Jin Medical International
ZJYL
$16.1M
$86.4K ﹤0.01%
+1,662
New +$105K
SCPH
3816
DELISTED
scPharmaceuticals
SCPH
$85.1K ﹤0.01%
19,554
-42,709
-69% -$188K
GLUE icon
3817
Monte Rosa Therapeutics
GLUE
$1.92B
$84.8K ﹤0.01%
+22,665
New +$116K
VATE icon
3818
INNOVATE Corp
VATE
$114M
$84.5K ﹤0.01%
13,976
+1,621
+13% +$10.7K
RGTI icon
3819
Rigetti Computing
RGTI
$4.7B
$84.4K ﹤0.01%
78,867
-226,715
-74% -$262K
TTEC icon
3820
TTEC Holdings
TTEC
$103M
$84.4K ﹤0.01%
14,349
-134,696
-90% -$987K
ASUR icon
3821
Asure Software
ASUR
$220M
$84.1K ﹤0.01%
10,015
-44,557
-82% -$337K
ITI
3822
DELISTED
Iteris, Inc.
ITI
$83.3K ﹤0.01%
19,246
+484
+3% +$2.19K
CIG icon
3823
CEMIG Preferred Shares
CIG
$6.09B
$83.2K ﹤0.01%
47,264
+28,042
+146% +$53.6K
PMVP icon
3824
PMV Pharmaceuticals
PMVP
$66.1M
$82.8K ﹤0.01%
+51,124
New +$92.2K
SFIX
3825
Stitch Fix
SFIX
$478M
$82.6K ﹤0.01%
+19,895
New +$53.9K

Similar funds

Squarepoint's Q2 2024 Portfolio in Review

As of Q2 2024, Squarepoint held 4,827 positions worth $60.5B, up 4.1% from $58.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Squarepoint's Q2 2024 filing shows 882 new, 1,455 increased, 1,567 reduced and 849 closed positions. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 1,286,013 shares worth $700M. The largest sale was Apple, an estimated $210M.

By sector, the portfolio is most concentrated in Technology at 9.1% of assets, up from 8.5% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Squarepoint's largest Q2 2024 buy was State Street SPDR S&P 500 ETF Trust: 1,286,013 shares worth $700M.
  • Squarepoint added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $1.29B increase.
  • Squarepoint's biggest Q2 2024 reduction was Apple, cutting an estimated $210M.
  • Squarepoint fully exited DraftKings in Q2 2024, selling an estimated $94.6M.
  • Squarepoint's ten largest holdings make up 18% of its $60.5B portfolio in Q2 2024.
  • Squarepoint opened 882 new positions and closed 849 in Q2 2024.
  • Squarepoint's portfolio value rose 4.1% quarter-over-quarter to $60.5B.

Based on Squarepoint's 13F filing for Q2 2024, filed 14 Aug 2024.